AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic ...

The president of Brazil Luiz Inácio Lula da Silva has bet big on biofuels - placing significant pressure on ecosystems and ...

regulatory or scientific nature. In contrast, it has been difficult for companies to get a concrete idea of how FuelEU Maritime will affect their business. That's why zero44 has developed the FuelEU ...

Tivic Health® Systems, Inc. , a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validated two granted European Patent Office (EPO) ...

BTIG raised the firm’s price target on Core Scientific (CORZ) to $19 from $15 and keeps a Buy rating on the shares. The analyst cites the ...

Macquarie raised the firm’s price target on Core Scientific (CORZ) to $19 from $16 and keeps an Outperform rating on the shares. Core, ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

BofA raised the firm’s price target on Boston Scientific (BSX) to $100 from $90 and keeps a Buy rating on the shares. The firm, which sees Boston Scientific having “best in medtech growth ...

Canaccord Genuity maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the stock's price target to $98 from $88. The adjustment follows the successful acquisition of Silk Road ...

On Monday, TD Cowen revealed an optimistic outlook for Boston Scientific Corporation (NYSE:BSX), raising the stock's price target from $86.00 to $100.00. The firm maintained a Buy rating on the shares ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and ...